In February 2025, Crown Laboratories acquired Revance Therapeutics, uniting two leaders in skincare and aesthetics under the Revance name. Following the acquisition, Revance appointed a new chief executive officer, Nadeem Moiz, on Oct. 1 to support its next phase of growth. Moiz, previously president, COO and CFO of the brand succeeds Jeff Bedard, the founder.
Log in to view the full article
In February 2025, Crown Laboratories acquired Revance Therapeutics, uniting two leaders in skincare and aesthetics under the Revance name. Following the acquisition, Revance appointed a new chief executive officer, Nadeem Moiz, on Oct. 1 to support its next phase of growth. Moiz, previously president, COO and CFO of the brand succeeds Jeff Bedard, the founder.
This transition reflects a long-term succession plan as the newly combined company aims to solidify its position as a leader in injectables, skin quality and skincare solutions. Moiz brings over 25 years of experience in strategy, operations and finance—a smooth progression from the role he played in Revance’s recent integration efforts.
MedEsthetics sat down with the newly appointed Moiz to get a sense of what his leadership will look like for the Revance brand in 2026.
As you step into the CEO role following this transformative acquisition, what’s your overarching vision for the newly combined Revance?
My vision is to build the most trusted and innovative aesthetics and skincare company—one that not only leads in science and results, but also in how we serve physicians, patients and customers. By bringing together the strengths of Crown and Revance, we have created a company that is focused on skin health for life, with unmatched expertise across regenerative, injectables and skincare. This is about more than scale—it’s about shaping the next era of aesthetics, grounded in science, authenticity and partnership with our customers.
Are there new technologies, services or innovations being introduced as a result of the acquisition and your new transition?
Absolutely. The acquisition allows us to leverage Crown’s world-class manufacturing and formulation capabilities with Revance’s clinical innovation and brand equity. You’ll see continued advancements in regenerative offerings, injectables and next-generation integrated skincare solutions that bridge professional and consumer experiences. We are also investing diligently in digital tools and data platforms that elevate patient engagement and physician connectivity.
You’ve already been deeply involved as President, COO and CFO—how will your leadership style evolve in this next chapter?
In my prior roles, my focus was on execution and integration—ensuring stability, growth and alignment across teams. As CEO, my role now expands to strategic vision, inspiration and helping our global team see the larger purpose of what we’re building as a global aesthetics and skincare company. I want to foster a culture where innovation, accountability and empathy coexist—where every team member feels ownership of our mission and pride in what we deliver.
How do you plan to continue building on the momentum created by the Crown acquisition and the brand unification under Revance?
Momentum comes from clarity and consistency. We’re aligning all of our efforts in science, commercial and operations—under one shared vision: to redefine excellence in aesthetics and skincare. Our integration teams have already made tremendous progress, and now the focus shifts to accelerating growth, deepening customer trust and expanding globally while maintaining the agility that has always defined both organizations.
Offering guidance for other brands that have recently acquired or are looking to acquire, how do you ensure that a brand being acquired maintains its core identity while still integrating into a larger company?
It starts with respect—for what made the acquired brand successful in the first place. The goal of integration isn’t to erase identity; it’s to amplify it within a stronger ecosystem. At Revance, we focus on preserving the authentic voice and values of each brand while aligning them around a common purpose. Integration succeeds when teams feel seen, valued and part of something bigger—not absorbed, but elevated.
What’s your best advice for founders or CEOs who are weighing whether an acquisition will make or break their brand?
An acquisition should be viewed as an evolution and a key element of growth. The right partnership will expand your ability to innovate, reach new audiences and scale impact—without compromising what makes your brand special. My advice: choose partners who share your values and vision, not just your market. When culture and purpose align, an acquisition doesn’t dilute identity—it accelerates it.
